Trial Profile
A double-blind, placebo-controlled, randomized, parallel-group study to evaluate the pharmacokinetics, pharmacodynamics, and safety of single subcutaneous doses of TV-1106 in healthy Japanese and Caucasian subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2016
Price :
$35
*
At a glance
- Drugs Albusomatropin (Primary)
- Indications Somatotropin deficiency
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 04 Nov 2016 New trial record